Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

A group has developed therapies that show promise for treating cancer and various other conditions.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The model and estimator can predict drug exposure in kidney transplant patients well.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

The document covers various dermatological treatments and conditions.

Wnt signaling is crucial for skin development and health, and its disruption can cause skin diseases.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Quercetin significantly helps hair growth by activating hair follicles and improving blood vessel formation around them.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.